Peptic ulcer, helicobacter pylori;Ulkuskrankheit, Helicobacter pylori

Therapeutische Umschau

Volumn 54, Issue 11, 1997, Pages 624-628

  Bauerfeind, P ^a   Wirth, H P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; UREA;

ANTIBIOTIC THERAPY; BREATH ANALYSIS; DISEASE ASSOCIATION; DISEASE CONTROL; HELICOBACTER PYLORI; INTESTINE LIPODYSTROPHY; PEPTIC ULCER; PROSTAGLANDIN METABOLISM; RELAPSE; REVIEW; RISK FACTOR; TREATMENT PLANNING; ZOLLINGER ELLISON SYNDROME;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; RISK FACTORS;

EID: 0030722035     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Duggan A., Logan R., Knifton A., Logan R.: Accuracy of near-patient blood tests for Helicobacter pylori (letter). Lancet 348, 617, 1996.
2. Thijs J. C., van Zwet A.A., Thijs W.J., Oey H.B., Karrenbeld A., Stellaard F., Luiji D.S., Meyer B. C., Kleibeuker J. H.: Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am. J. Gastroenterol. 91, 2125, 1996.
3. Bytzer P., Hansen J.M., Schaffaluzky de Muckadell O.B.: Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 343, 811, 1994.
4. Dickey W., Kenny B. D., McConnell J. B.: Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment. Pharmacol. Ther. 10, 289, 1996.
5. Figura N.: Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment. Pharmacol. Ther. 10, 79, 1996.
6. Walan A., Bader J.P., Classen M., Lawers C.B., Piper D. W., Rutgersson K., Eriksson, S.: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N. Engl. J. Med. 320, 69, 1989.
7. Koch M., Dezj A., Ferrario F., Capurso I.: Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Arch. Intern. Med. 156, 2321, 1996.
8. Hawkey C.J., Swannell A.J., Eriksson S., Walan A., Bjersing M., Jallinder M., Langström G., Yeomans N.D.: Lower frequency of gastroduodenal ulcers and erosions and dyspeptic symptoms in NSAID ulcers during maintenance with omeprazole compared to ranitidine (abstract). Gastroenterology 89, A131, 1996.
9. Caspary W.F., Arnold R., Bayerdorffer E., Behrens R., Birkner B., Braden B., Domschke W., Labenz J., Koletzko S., Malfertheiner P., Menge H., Rosch W., Schepp W., Strauch M., Stolte M.: Diagnostik und Therapie der Helicobacter-pylori-Infektion. Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z. Gastnoenterol. 34, 392, 1996.
10. Soll A.H.: Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 275, 622, 1996.
11. De Boer W.A., Tytgat G.N.: How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. Eur. J. Gastroenterol. Hepatol. 8, 709, 1996.